middle.news
Elixinol’s Revenue Climbs 12.8% as Profitability Target Looms in Q4
4:28am on Saturday 30th of August, 2025 AEST
•
Consumer Staples
Read Story
Elixinol’s Revenue Climbs 12.8% as Profitability Target Looms in Q4
4:28am on Saturday 30th of August, 2025 AEST
Key Points
12.8% revenue growth to $7.6 million in H1 2025
Gross margin improved to 37%, aided by e-commerce expansion
Adjusted EBITDA loss widened to –$2.2 million due to integration costs
Healthy Chef acquisition and e-commerce growth key revenue drivers
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Elixinol Wellness (ASX:EXL)
OPEN ARTICLE